About ABUS

Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease.
Primary Exchange: NASDAQ
SIC
NAICS Pharmaceutical Preparation Manufacturing

ABUS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.01% 0.000121054 63 K 63374
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.01% 6.98307E-05 7 K 7106
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.0% 1.55135E-05 5 K 5105
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.0% 2.30434E-05 9 K 9163
SBIO ALPS Medical Breakthroughs ETF 201.2 M 2.01211E+08 71 71 0.25% 0.0025 494 K 493908
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.0% 4E-05 11 K 11029
VTWO Vanguard Russell 2000 ETF 1.6 B 1.6E+09 2,013 2013 0.01% 7E-05 118 K 117821
VTWV Vanguard Russell 2000 Value ETF 247.5 M 2.475E+08 1,376 1376 0.01% 0.00011 26 K 26290
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.03% 0.0003 2.3 M 2283890
IWC iShares Microcap ETF 916.2 M 9.16246E+08 1,452 1452 0.03% 0.0003 313 K 313186
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.01% 0.0001 2.8 M 2754870
IWN iShares Russell 2000 Value ETF 9.2 B 9.22952E+09 1,371 1371 0.01% 0.0001 902 K 902037
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.0% 0 300 K 300131
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 51 K 50985

Wait, Before You Leave...